FDA approves Sarclisa Escena, first anticancer drug via on-body injector for multiple myeloma
The FDA has approved Sarclisa Escena, a subcutaneous formulation of the multiple myeloma drug Sarclisa, administered via the innovative CirCLIQ on-body injector (OBI). This is the first anticancer treatment approved for delivery through an on-body in...
